LAURA DINARDO: Open Payments
NPI 1114691318 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 58 payments from 6 companies in 2025. Trend: 2023 $1,257 · 2024 $1,339 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $802 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VRAYLAR, FANAPT, SPRAVATO, CAPLYTA, REXULTI, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
